Stock Events

Stock Events

Silexion Therapeutics (SLXN) Q3 2024 Earnings

13AugConfirmed

Q1 1

Q3 2024

-0.98

-0.69

-0.4

-0.11

Details

Expected EPS

N/A

Actual EPS

-0.11

Surprise EPS

-0.11

Surprise Percent

+∞%

Description

Silexion Therapeutics (SLXN) has reported earnings of -0.11 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.